Guided Therapeutics Price/Sales
What is the Price/Sales of Guided Therapeutics?
The Price/Sales of Guided Therapeutics, Inc. is 111.26
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Health Care sector on OTC compared to Guided Therapeutics
What does Guided Therapeutics do?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Companies with price/sales similar to Guided Therapeutics
- Hansa Trust A Shares has Price/Sales of 110.56
- Gadsden Properties has Price/Sales of 110.77
- Gadsden Properties has Price/Sales of 110.77
- iShares Trust - iShares Russell 2000 ETF has Price/Sales of 110.94
- Fairfax India has Price/Sales of 111.02
- BlackRock Maryland Municipal Bond Trust has Price/Sales of 111.21
- Guided Therapeutics has Price/Sales of 111.26
- Repro India has Price/Sales of 111.79
- Hansa Trust Plc has Price/Sales of 111.96
- ASA Gold and Precious Metals Ltd has Price/Sales of 112.21
- Sanwaria Consumer has Price/Sales of 112.41
- BlackRock MuniVest Fund has Price/Sales of 113.31
- Wilmington Capital Management has Price/Sales of 114.06